Skip to main content
Clinical Trials/JPRN-UMIN000016870
JPRN-UMIN000016870Completed未知

Combination therapy with intravitreal tissue plasminogen activator and ranibizumab for subfoveal type 2 choroidal neovascularization - Intravitreal tPA and ranibizumab for type 2 choroidal neovascularization

agoya City University Graduate School of Medicine0 sites20 target enrollmentStarted: March 23, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
20